Results 1 to 10 of about 24,601 (185)
Atrioventricular Block After EVOQUE Transcatheter Tricuspid Valve Replacement
Structural HeartHighlights • Based on a real-world study of 106 Evoque transcatheter tricuspid valve replacement (TTVR) recipients, a total of 14 (25%) cases of new atrioventricular (AV) block occurred after Evoque implantation in the 55 patients without prior ...
Bryan Zweig, Mohamad Raad, John Dawdy
exaly +8 more sources
JACC: Cardiovascular Interventions, 2022 OBJECTIVES The aim of this study was to report the midterm outcomes at 1 year in the expanded first-in-human experience with the transfemoral EVOQUE system (Edwards Lifesciences) for tricuspid regurgitation (TR).
Neil P Fam, Djeven P Deva, Molly Szerlip
exaly +3 more sources
JACC: Cardiovascular Interventions, 2021 OBJECTIVES The purpose of this observational first-in-human experience was to investigate the feasibility and safety of the EVOQUE tricuspid valve replacement system and its impact on short-term clinical outcomes.
Isaac George, John Webb, Mark Hensey
exaly +3 more sources
EVOQUE Tricuspid Valve Replacement System: State-of-the-Art Screening and Intraprocedural Guidance
JACC: Cardiovascular InterventionsWith the recent approval of the transcatheter EVOQUE tricuspid valve replacement system to treat severe, symptomatic tricuspid regurgitation, there is a need to define the appropriate patient population and anatomical considerations for this device.
Mani A Vannan +2 more
exaly +5 more sources
Structural HeartHighlights • Transcatheter closure of paravalvular leak of the EVOQUE valve is feasible and can be done from a transfemoral or transjugular approach.• Preoperative cardiac computed tomography is useful to characterize the location and size of the ...
G. Giustino +9 more
semanticscholar +5 more sources
Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices
Structural HeartEach reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj +3 more sources
Transcatheter Mitral Valve Replacement With the Transseptal EVOQUE System.
JACC: Cardiovascular Interventions, 2020 OBJECTIVES The aim of this study was to examine the initial experience with a novel transseptal transcatheter mitral valve replacement (TMVR) system. BACKGROUND Transseptal TMVR may offer a less invasive option than surgery for mitral regurgitation (MR)
J. Webb +23 more
semanticscholar +3 more sources
Transesophageal Echocardiography and Intracardiac Echocardiography to Guide EVOQUE
JACC: Case ReportsObjective We demonstrate a step-by-step intraprocedural imaging guide using transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE) to guide EVOQUE in cases with poor intraprocedural imaging.
N. Quader +7 more
semanticscholar +3 more sources
EARLY EXPERIENCE WITH THE EVOQUE MITRAL VALVE REPLACEMENT SYSTEM
Journal of the American College of Cardiology, 2020 Transcatheter mitral treatment options have emerged as an alternative to surgery, with transseptal delivery as the preferred approach. We report the 30-day results from the initial experience with the EVOQUE Mitral Valve Replacement System (Edwards ...
J. Webb +24 more
semanticscholar +2 more sources
European Heart Journal - Case ReportsBackground Tricuspid regurgitation (TR) is a disease with significant morbidity and mortality rates. Besides surgery and transcatheter edge-to-edge repair (TEER), transcatheter tricuspid valve replacement has evolved as a possible treatment option in ...
Tobias Schmidt +2 more
exaly +2 more sources